KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme Group (CME) Notes Payables: 2009-2024

Historic Notes Payables for Cme Group (CME) over the last 4 years, with Dec 2024 value amounting to $749.8 million.

  • Cme Group's Notes Payables was N/A to $749.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $749.8 million, marking a year-over-year change of. This contributed to the annual value of $749.8 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q4 2024, Cme Group's Notes Payables is $749.8 million, which was up 0.01% from $749.7 million recorded in Q3 2024.
  • In the past 5 years, Cme Group's Notes Payables ranged from a high of $749.8 million in Q4 2024 and a low of $14.5 million during Q3 2022.
  • Over the past 3 years, Cme Group's median Notes Payables value was $749.3 million (recorded in 2024), while the average stood at $435.0 million.
  • Its Notes Payables has fluctuated over the past 5 years, first plummeted by 98.06% in 2022, then soared by 4,496.93% in 2024.
  • Over the past 4 years, Cme Group's Notes Payables (Quarterly) stood at $749.4 million in 2021, then plummeted by 97.86% to $16.0 million in 2022, then reached $16.3 million in 2023, then surged by 4,496.93% to $749.8 million in 2024.
  • Its last three reported values are $749.8 million in Q4 2024, $749.7 million for Q3 2024, and $749.5 million during Q2 2024.